System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ahmed Benyoucef is an expert in Radiotherapy at Centre Henri Becquerel (France). Ahmed Benyoucef has authored 42 publications, the most recent in 2026, and is an investigator in 8 clinical trials, 3 of them ongoing. SLR score: 111 (community average: 125). How the SLR is computed.

LeadR Profile

Ahmed Benyoucef Centre Henri Becquerel France
111 ScienceLeadR Reputation 111

Unlock

Register Login
Network Map

Radiotherapy

Subspecialties: Oncology - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026
Source: PubMed

Centre Henri Becquerel

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 42

Citations

Citations: 674 1st author: 0 Last author: 1 Unique author: 0

Main journals

Int J Radiat Oncol Biol Phys 6
Radiother Oncol 5
Cancer Radiother 4
Cancer Res 4
Ann Oncol 2

Best Journals

Ann Oncol 2
J Clin Oncol 2
Lancet 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial.
PMID 42636837 — radiotherapy, urinary bladder, progression-free survival, androgens, neoplasms, prostate, prostate-specific antigen, drug-related side effects and adverse reactions, urethra, prostatic neoplasms, therapeutics		Lancet Oncol Top journal20261
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.
PMID 41794436 — radiotherapy, breast neoplasms, neoplasms, breast, morbidity		Lancet Top journal20260
Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective Study.
PMID 41577610 — urinary bladder, urinary bladder neoplasms, muscles, retrospective studies, neoplasms, therapeutics, non-muscle invasive bladder neoplasms		Eur Urol Oncol20260
Comprehensive radiotherapy quality assurance analysis from individual DICOM data in the HyptoG-01 phase 3 trial.
PMID 41173355 — radiotherapy, breast, beds, therapeutics, medical oncology		Radiother Oncol20253
Late Toxicities and Quality of Life after a Radiation Boost for Breast DCIS: BONBIS Randomized Trial.
PMID 40752655 — radiotherapy, quality of life, radiobiology, carcinoma, intraductal, noninfiltrating, breast		Int J Radiat Oncol Biol Phys20250

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 3 2

By status:

Active not recruiting 2
Not yet recruiting 2
Recruiting 2
Completed 1
Unknown 1

By type:

Interventional 7
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Treatment with darolutamide radiation therapy for patients with a castration resistant cancer and metastases detected by functional imaging
2023-509787-15-00 — radiotherapy, safety, lymph nodes, neoplasms, classification, prostate, positron emission tomography computed tomography, neoplasm metastasis, lymph, prostatic neoplasms, castration, therapeutics		Phase 3Not yet recruiting2025
Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy Impact of Informing Them of AI predicted Risk
NCT07187726 — radiotherapy, quality of life, lymph nodes, breast neoplasms, communication, neoplasms, lymph, breast, physicians, therapeutics, artificial intelligence, unilateral breast neoplasms, lymphedema		N/ARecruiting2025
Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT GETUG V11)
NCT07043543 — radiotherapy, urinary bladder, urinary bladder neoplasms, mitomycin, neoplasms, drug therapy, fluorouracil, therapeutics, capecitabine, chemotherapy		N/ANot yet recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS